High School Student Researchers Find New Brain Tumor Drug Targets Using AI
GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.
- GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.
- Olsen, a student at Sevenoaks School in Kent, UK, began interning at Insilico Medicine in 2021, after discovering her interest in neurobiology and technology.
- Ren, a student at Shanghai High School International Division, has an interest in biology and biomarkers and joined them in the summer of 2022.
- He discovered generative AI drug discovery company Insilico Medicine whose founder and CEO, Alex Zhavoronkov, PhD, connected him with Olsen.